Industry

Tailoring pet health: Nestlé’s new kit personalizes nutrition based on pet microbiome analysis

The new kit is part of the 'Petivity by Purina Petcare' ecosystem, which uses advanced tools to improve pet health and longevity through enhanced nutritional science.

Consumer behavior in probiotic consumption

MicrobiomePost carried out a research analysis in collaboration with Analytics Arts to find out more about the motivations and frequency of probiotic consumption and the level of consumer information.

MaaT Pharma demonstrates significant survival benefits with MaaT013 in Acute Graft-Versus-Host Disease

These findings underscore MaaT013's potential as a third-line treatment option, where traditional treatments often fall short.

Revolutionizing skin health: advanced probiotic-oil suspension to transform microbial balance in seborrheic dermatitis

Researchers at the San Gallicano Dermatological Institute in Rome, Italy, conducted an open-label exploratory trial to assess the therapeutic potential of EUTOPLAC, a topical probiotic containing Lactobacillus crispatus P 17631…

EnteroBiotix embarks on groundbreaking phase 2 trial for innovative IBS treatment

Launching a new frontier in IBS management: the 'TrIuMPH' trial sets the stage with EBX-102-02, a pioneer in microbiome-based therapy.

Innovative partnership between Resilient Biotics and Cosmosid sets a new horizon in microbiome research

The two companies will work on identifying, analyzing, and understanding respiratory tract microbiome systems.

Expanding Horizons in Microbiome Therapeutics: List Biotherapeutics and Sacco System Forge Strategic Alliance

This partnership emerges as a strategic move to capitalize on the expanding global microbiome market.

Probiotics for women’s health: new evidence in post-menopausal women

Harnessing the benefits of L. plantarum PBS067, L. rhamnosus LRH020, and B. lactis BL050 for post-menopausal symptom relief.

The PICASSO trial: painting a new future for melanoma patients

MaaT Pharma indicates completion of patient recruitment for the Phase 2a RCT Evaluating MaaT013 in combination with immune checkpoint inhibitors in metastatic melanoma.

Clinical Microbiomics acquires DNASense to expand frontier technologies

This strategic acquisition is set to reshape the landscape of microbiome research, extending its applications far beyond human health.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top